IDL Biotech: First step towards US
Research Note
2019-07-11
12:28
Yesterday IDL announced that a pre-submission request has been filed to FDA regarding UBC Rapid. We reiterate our forecast of a US launch in late 2022/early 2023.
LS
Ludvig Svensson
Disclosures and disclaimers